Doron Steger, MS

Doron Steger founded DZS Software Solutions, Inc. in 1984 and now serves as a member of the Scientific Consulting and Advisory Board. Prior to the acquisition of DZS Clinical Services by WDB Holdings, Steger served as the CEO of DZS Software Solutions, Inc. The company consisted of two divisions: DZS Clinical Services, providing full-service CRO capabilities, and a software division, providing a complete suite of proprietary clinical software tools. Steger has led DZS through a variety of notable industry accomplishments including support for pivotal studies in oncology, anti-infectives and multiple sclerosis as well as pioneering efforts in the treatment of wounded U.S. soldiers, and approval of the first PEGylation product to be brought to market.

With more than 40 years in the industry, Steger also has had positions at Sandoz Pharmaceuticals, Inc. and Hoechst-Roussel Pharmaceuticals, Inc.

Education and Memberships

  • MS, Physics, Rutgers University, New Brunswick, NJ
  • MS, Computer Science, Rutgers University, New Brunswick, NJ